BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 8130953)

  • 1. Contrast enhancement in primary tumors of the brain and spinal cord.
    Castillo M
    Neuroimaging Clin N Am; 1994 Feb; 4(1):63-80. PubMed ID: 8130953
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Magnetic resonance imaging contrast agents: theory and application to the central nervous system.
    Bronen RA; Sze G
    J Neurosurg; 1990 Dec; 73(6):820-39. PubMed ID: 2230966
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Computed tomography and magnetic resonance imaging of intramedullary spinal cord tumors.
    Miyasaka K; Akino M; Abe S; Isu T; Iwasaki Y; Abe H
    Acta Radiol Suppl; 1986; 369():738-40. PubMed ID: 2980612
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Imaging of central nervous system tumors.
    Dillon WP
    Curr Opin Radiol; 1991 Feb; 3(1):46-50. PubMed ID: 2025506
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Radiological features of primary central nervous system lymphoma].
    Nakazawa T; Matsuda M; Nakasu S; Hanada J; Koyama T
    Nihon Geka Hokan; 1990 Mar; 59(2):141-7. PubMed ID: 2130775
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Central nervous system tumors in children: detection by magnetic resonance imaging.
    Kucharczyk W; Brant-Zawadzki M; Sobel D; Edwards MB; Kelly WM; Norman D; Newton TH
    Radiology; 1985 Apr; 155(1):131-6. PubMed ID: 3975390
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Brain metastases--comparison of gadodiamide injection-enhanced MR imaging at standard and high dose, contrast-enhanced CT and non-contrast-enhanced MR imaging.
    Akeson P; Larsson EM; Kristoffersen DT; Jonsson E; Holtås S
    Acta Radiol; 1995 May; 36(3):300-6. PubMed ID: 7742127
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Image interpretation session. Ganglioglioma.
    Radiographics; 1995 Jan; 15(1):228-30. PubMed ID: 7899606
    [No Abstract]   [Full Text] [Related]  

  • 9. [Value of contrast enhancement with Gd-DTPA in MRI of brain tumors. A comparison with X-ray CT].
    Tsuji T; Kishikawa T; Ikezaki K; Fujii K; Matsumoto S; Koga T
    Fukuoka Igaku Zasshi; 1987 Dec; 78(12):578-97. PubMed ID: 3447928
    [No Abstract]   [Full Text] [Related]  

  • 10. Tumors of the central nervous system studied by computed tomography and ultrasound.
    Enzmann DR; Wheat R; Marshall WH; Bird R; Murphy-Irwin K; Karbon K; Hanbery J; Silverberg GD; Britt RH; Shuer L
    Radiology; 1985 Feb; 154(2):393-9. PubMed ID: 3880911
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The contrast enhancement of brain and spinal cord tumors using Gd-DTPA in magnetic resonance tomography with an extra-low magnetic-field intensity].
    Kornienko VN; Pronin IN; Turkin AM; Fadeeva LM
    Zh Vopr Neirokhir Im N N Burdenko; 1993; (4):13-7. PubMed ID: 8296501
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of magnetic resonance imaging in differentiating compartmental location of spinal tumors.
    Khanna AJ; Shindle MK; Wasserman BA; Gokaslan ZL; Gonzales RA; Buchowski JM; Riley LH
    Am J Orthop (Belle Mead NJ); 2005 Oct; 34(10):472-6. PubMed ID: 16304794
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distinguishing tumefactive demyelinating lesions from glioma or central nervous system lymphoma: added value of unenhanced CT compared with conventional contrast-enhanced MR imaging.
    Kim DS; Na DG; Kim KH; Kim JH; Kim E; Yun BL; Chang KH
    Radiology; 2009 May; 251(2):467-75. PubMed ID: 19261924
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Brain and spinal tumors: magnetic resonance imaging using gadolinium-diethylenetriamine pentaacetic acid (Gd-DTPA)].
    Fang YX
    Zhonghua Yi Xue Za Zhi; 1989 Jun; 69(6):305-7, 22. PubMed ID: 2804747
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nonenhancing tumors of the spinal cord.
    White JB; Miller GM; Layton KF; Krauss WE
    J Neurosurg Spine; 2007 Oct; 7(4):403-7. PubMed ID: 17933314
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A multislice gradient-echo sequence for contrast medium-enhanced MR diagnosis of intracranial tumors].
    Schörner W; Sander B; Kornmesser W; Laniado M; Nakamura T; Felix R
    Rofo; 1988 Jun; 148(6):665-73. PubMed ID: 2837804
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MR of cranial and spinal meningeal carcinomatosis: comparison with CT and myelography.
    Krol G; Sze G; Malkin M; Walker R
    AJR Am J Roentgenol; 1988 Sep; 151(3):583-8. PubMed ID: 3261521
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MRI features of spinal ganglioglioma.
    Cheung YK; Fung CF; Chan FL; Leong LL
    Clin Imaging; 1991; 15(2):109-12. PubMed ID: 1913309
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Contrast-enhanced magnetic resonance imaging of tumours of the central nervous system: a clinical review.
    Graif M; Steiner RE
    Br J Radiol; 1986 Sep; 59(705):865-73. PubMed ID: 3756381
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Contrast enhancement in spinal MR imaging.
    Breger RK; Williams AL; Daniels DL; Czervionke LF; Mark LP; Haughton VM; Papke RA; Coffer M
    AJR Am J Roentgenol; 1989 Aug; 153(2):387-91. PubMed ID: 2750625
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.